---
title: "Prioritizing putative influential genes in cardiovascular disease susceptibility by applying tissue-specific Mendelian randomization"
description: |
  * **Core Method**: The study developed a multi-step analysis pipeline integrating eQTL-wide association, two-sample Mendelian randomization (MR), and multiple-trait colocalization to investigate the causal pathway from genetic variants to cardiovascular traits.
  * **Key Findings**: MR analysis provided evidence for **tissue-specific genetic effects** on traits like BMI (**ADCY3**) and cholesterol (**FADS1** and **SORT1** in liver tissue), demonstrating that the biological context of gene expression is critical.
  * **Mechanism Elucidation**: Colocalization analyses suggested that **DNA methylation** may also play a role alongside gene expression, particularly at the FADS1/TMEM258 locus, and the pipeline identified a total of **233 candidate association signals** for future functional studies.
date: last-modified
categories: [GWAS, dna methylation, gene expression, mendelian randomization, tissue specificity]
---

**PubMed:** [30704512](https://pubmed.ncbi.nlm.nih.gov/30704512/)
**DOI:** [10.1186/s13073-019-0613-2](https://doi.org/10.1186/s13073-019-0613-2)
**Overview generated by:** Gemini 2.5 Flash, 28/11/2025

## Key Findings

The study's primary finding is the successful development and application of an analysis pipeline that integrates molecular and genetic data to prioritize genes whose tissue-specific expression or DNA methylation status influences cardiovascular disease (CVD) susceptibility.

* **Tissue-Specific Effects Demonstrated (MR):** The Mendelian randomization (MR) analysis provided evidence for causal, **tissue-specific effects** at multiple genetic loci.
    * Specific insights were gained at the **ADCY3** locus for **body mass index (BMI)**.
    * The **FADS1** locus showed effects on **cholesterol** levels.
    * The **SORT1** locus influence on cholesterol and ApoB was found to colocalize specifically in **liver tissue**, but not whole blood, highlighting the importance of tissue specificity.
* **DNA Methylation Role:** Multiple-trait colocalization (moloc) analyses suggested that changes in **DNA methylation** at the promoter region upstream of **FADS1/TMEM258** may work in conjunction with gene expression to affect cardiovascular trait variation.
* **Gene Prioritization:** Applying the full pipeline genome-wide identified **233 association signals** representing promising candidate genes for further functional evaluation.

## Study Design and Methods

### Analysis Pipeline

The authors developed a five-step analysis pipeline to move from genetic variants to putative causal genes and mechanisms:

1.  **Exposure and Outcome Association (eQTLWAS):** An **expression quantitative trait loci-wide association study (eQTLWAS)** was performed using cis-eQTLs to uncover genetic variants associated with both nearby gene expression and cardiovascular traits.
2.  **Fine-Mapping:** Causal variants at associated loci were prioritized using **FINEMAP software** in the ALSPAC dataset.
3.  **Causal Inference (Tissue-Specific MR):** **Two-sample Mendelian randomization (MR)** using the Wald ratio method was applied. The exposure was gene expression derived from the Genotype-Tissue Expression Project (GTEx) across **cardiovascular-relevant tissues** (e.g., adipose, liver, heart, artery) and brain areas. The outcome data came from large-scale GWAS consortia for traits like cholesterol, BMI, and triglycerides.
4.  **Shared Causal Variant (Multiple-Trait Colocalization):** **Bayesian multiple-trait colocalization (moloc)** was used to assess whether the same underlying genetic variant influences both gene expression and the cardiovascular trait, and/or **DNA methylation** (using ARIES mQTL data), which helps rule out linkage disequilibrium as the sole explanation.
5.  **Genome-Wide Application:** The pipeline was applied genome-wide using summary statistics from large-scale GWAS to discover novel signals.

### Data Sources

* **Discovery Cohort:** Avon Longitudinal Study of Parents and Children (**ALSPAC**) was used to identify initial associations.
* **eQTL Data:** Initial eQTLs were obtained from the Framingham Heart Study (**FHS**) for eQTLWAS. For the tissue-specific MR, data from the Genotype-Tissue Expression Project (**GTEx v6p**) across various tissues was used.
* **mQTL Data:** DNA methylation data was sourced from the Accessible Resource for Integrated Epigenomics Studies (**ARIES**) cohort (ALSPAC mothers).
* **GWAS Outcomes:** Summary statistics were taken from major GWAS consortia for cardiovascular and anthropometric traits.

## Conclusions and Recommendations

The study confirms that the genetic susceptibility to complex diseases, such as CVD, is modulated by **differential changes in tissue-specific gene expression and DNA methylation**.

The authors conclude that the developed pipeline is a valuable resource for **elucidating biological mechanisms** and **prioritizing putative causal genes** at loci where conventional GWAS provides ambiguous results due to co-regulated proximal genes. The findings, particularly those that suggest genetic loci influence cardiovascular traits early in the life course (via validation in ALSPAC), allow for a longer window of intervention for disease prevention. Future research requires more comprehensive tissue-specific DNA methylation data to further validate these complex causal pathways.